+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Liposomal muramyl tripeptide up-regulates interleukin-1 alpha, interleukin-1 beta, tumor necrosis factor-alpha, interleukin-6 and interleukin-8 gene expression in human monocytes



Liposomal muramyl tripeptide up-regulates interleukin-1 alpha, interleukin-1 beta, tumor necrosis factor-alpha, interleukin-6 and interleukin-8 gene expression in human monocytes



Journal of Pharmacology and Experimental Therapeutics 268(2): 1032-1039



Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine (L-MTP-PE) is a new biologic agent presently in clinical trials for metastatic osteosarcoma and melanoma. The mechanism of L-MTP-PE antitumor activity is linked to its activation of monocyte tumoricidal function. The purpose of this study was to determine whether L-MTP-PE affected the expression of cytokine genes in monocytes. Monocyte interleukin (IL)-1 alpha, IL-1 beta, IL-6, IL-8 and tumor necrosis factor (TNF)-alpha expression were all up-regulated after a 2-h incubation with L-MTP-PE. The increased expression of IL-1 alpha, IL-1 beta, IL-6 and IL-8 persisted up to 72 h. Increased TNF-alpha expression declined by 24 h. The kinetics of cytokine expression stimulated by L-MTP-PE were different from those seen after lipopolysaccharide (LPS) stimulation. Lipopolysaccharide stimulation caused a rapid increase in cytokine expression followed by a rapid decline. L-MTP-PE did not affect the expression of these cytokines in lymphocytes, nor did L-MTP-PE upregulate IL-2 expression in lymphocytes. The early up-regulation of all five cytokines was due to an increase in the transcriptional activity. Modification of mRNA stability was not detected at 2 h but was seen after a 24-h exposure to L-MTP-PE. The subsequent production and secretion of these cytokine proteins may play a role in L-MTP-PE antitumor activity.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046554770

Download citation: RISBibTeXText

PMID: 8113959


Related references

Detection of intracytoplasmic interleukin-1 alpha, interleukin-1 beta, interleukin-6 and tumour necrosis factor alpha expression in human monocytes using two-colour immunofluorescence flow cytometry. International Journal of Experimental Pathology 73(5): A15, 1992

Modulation of tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6, interleukin-8, and granulocyte/macrophage colony-stimulating factor expression in human monocytes by an endogenous anxiogenic benzodiazepine ligand, triakontatetraneuropeptide: evidence for a role of prostaglandins. Molecular Pharmacology 43(1): 64-69, 1993

Interleukin 2 il 2 stimulates the production of interleukin 1 beta il 1 beta interleukin 1 alpha il 1 alpha and tumor necrosis factor alpha tnf alpha from human peripheral blood mononuclear cells pbmc. Journal of Leukocyte Biology 42(5): 545, 1987

Interleukin-1 beta, interleukin-5, interleukin-6, interleukin-8, and tumor necrosis factor-alpha in chronic sinusitis: response to systemic corticosteroids. American Journal of Rhinology 14(6): 367-373, 2001

Human alveolar macrophage gene expression of interleukin-8 by tumor necrosis factor-alpha, lipopolysaccharide, and interleukin-1 beta. American Journal of Respiratory Cell and Molecular Biology 2(4): 321-326, 1990

The detection of intracytoplasmic interleukin-1 alpha, interleukin-1 beta and tumour necrosis factor alpha expression in human monocytes using two colour immunofluorescence flow cytometry. Journal of Immunological Methods 154(1): 11-20, 1992

Alpha 1-acid glycoprotein potentiates lipopolysaccharide-induced secretion of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha by human monocytes and alveolar and peritoneal macrophages. European Journal of Immunology 22(10): 2687-2695, 1992

Dynamics and regulation of macrophage tumor necrosis factor alpha tnf interleukin 1 alpha il 1 alpha and interleukin 1 beta il 1 beta gene expression by arachidonate metabolites. Powanda, M C , Et Al (Ed ) Progress in Leukocyte Biology, Vol 8 Monokines And Other Non-Lymphocytic Cytokines; International Workshop, Hilton Head Island, South Carolina, Usa, December 6-10, 1987 Xxix+414p Alan R Liss, Inc : New York, New York, Usa Illus 61-66, 1988

Synergistic effect of interleukin-1 beta and tumor necrosis factor alpha on interleukin-8 gene expression in synovial fibroblasts. Evidence that interleukin-8 is the major neutrophil-activating chemokine released in response to monokine activation. Arthritis and Rheumatism 36(9): 1295-1304, 1993

Differential expression of tumor necrosis factor alpha and interleukin 1-beta compared with interleukin 6 in monocytes from human immunodeficiency virus-positive individuals measures by polymerase chain reaction. Journal of Acquired Immune Deficiency Syndromes 7(2): 109-115, 1994

Expression of macrophage colony-stimulating factor (M-CSF), interleukin-6, (IL-6), interleukin-1 beta (IL-1 beta), interleukin-11 (IL-11) and tumour necrosis factor-alpha (TNF-alpha) in p53-characterised human ovarian carcinomas. European Journal of Cancer 33(13): 2246-2251, 1997

Interleukin 8 modulates interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha release from normal human mononuclear cells. Immunopharmacology 27(3): 207-214, 1994

Purified staphylococcal lipase induces tumor necrosis factor-alpha , interleukin-1-beta , and interleukin-6 from human blood monocytes. Clinical & Investigative Medicine 16(4 Suppl. ): B78, 1993

Dual regulatory effects of interferon-alpha, -beta, and -gamma on interleukin-8 gene expression by human gingival fibroblasts in culture upon stimulation with lipopolysaccharide from Prevotella intermedia, interleukin-1alpha, or tumor necrosis factor-alpha. Journal of Dental Research 77(8): 1597-1605, 1998

Cytokine (interleukin-1 alpha, interleukin-1 beta, tumor necrosis factor alpha, and interleukin-6)-possessing cells in lymph nodes of malignant lymphoma. Pathology Research and Practice 189(1): 18-25, 1993